Synchron Australia

🧠 Brain-Computer Interfaces· 📍 Melbourne, Australia

Overview

Synchron's Australian operations and clinical trial hub developed the Stentrode, a minimally invasive endovascular BCI implanted via a blood vessel without open brain surgery. Their device has enabled ALS patients to control computers and smartphones through motor imagery.

More in Brain-Computer Interfaces

Synaptogen Inc.

Boston, MA

Neurode Inc.

San Francisco, CA

Augmental

Synchroni

Aleva Neurotherapeutics

Lausanne, Switzerland

Battelle Memorial Institute – Neurotechnology

Columbus, USA

Latest industry news

FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD

2026-09-03 · Policy

Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%

2026-09-02 · Industry

Merge Labs and Butterfly Network Unite to Push Ultrasound-Based BCIs Into the Mainstream

2026-09-01 · Industry

FDA Grants CorTec Second Breakthrough Device Designation for Its Brain-Computer Interface

2026-08-31 · Policy

Company details

Is this your company?

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Claim & upgrade listing

Advertise

Reach neurotech professionals

Newsletter sponsorships, featured listings, and sponsored articles.

View packages →